Qiagen NV
QGEN48.340USD
-0.380-0.78%
종가 07/03, 13:00（ET）시세는 15분 지연됩니다
10.47B시가총액
111.75P/E TTM
자세한 내용은 Qiagen NV 회사
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
회사 정보
종목 코드 QGEN
회사 이름Qiagen NV
상장일Sep 01, 1996
설립일1996
CEOMr. Thierry Bernard
직원 수5765
유형Ordinary Share
회계 연도 종료Sep 01
주소Hulsterweg 82
도시VENLO
증권 거래소NYSE Consolidated
국가Netherlands
우편 번호5912 PL
전화31773556600
웹사이트https://www.qiagen.com/
종목 코드 QGEN
상장일Sep 01, 1996
설립일1996
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
24.00
--
Ms. Eva van Pelt
Ms. Eva van Pelt
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert van Meurs
Mr. Bert van Meurs
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
수익 분석
통화: USD마지막 업데이트: Wed, Jul 2
통화: USD마지막 업데이트: Wed, Jul 2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
사업별USD
이름
수익
비율
Consumables and Related Revenues
435.06M
89.99%
Instrumentation
48.39M
10.01%
지역별USD
이름
수익
비율
United States
232.85M
48.16%
Europe & Middle East & Africa
160.64M
33.23%
Asia, Pacific & Rest of the World
68.83M
14.24%
Other Americas
21.13M
4.37%
사업별
지역별
사업별USD
이름
수익
비율
Consumables and Related Revenues
435.06M
89.99%
Instrumentation
48.39M
10.01%
주식 보유 통계
마지막 업데이트: Sat, Jun 14
마지막 업데이트: Sat, Jun 14
주주
주주 유형
주주
주주
비율
Wellington Management Company, LLP
11.29%
MFS Investment Management
11.20%
BlackRock Institutional Trust Company, N.A.
9.31%
The Vanguard Group, Inc.
4.06%
Amundi Asset Management, SAS
1.94%
Other
62.21%
주주
주주
비율
Wellington Management Company, LLP
11.29%
MFS Investment Management
11.20%
BlackRock Institutional Trust Company, N.A.
9.31%
The Vanguard Group, Inc.
4.06%
Amundi Asset Management, SAS
1.94%
Other
62.21%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
46.16%
Investment Advisor
29.88%
Hedge Fund
3.22%
Research Firm
3.21%
Sovereign Wealth Fund
1.87%
Pension Fund
1.58%
Holding Company
1.17%
Bank and Trust
1.07%
Individual Investor
0.44%
Other
11.41%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
974
192.57M
88.92%
+36.97M
2025Q1
1017
179.03M
82.67%
+27.58M
2024Q4
1010
129.03M
59.70%
-70.06M
2024Q3
1010
183.22M
84.72%
-23.62M
2024Q2
1002
184.34M
84.75%
+8.40M
2024Q1
988
165.20M
76.61%
-7.18M
2023Q4
993
165.11M
76.72%
-10.52M
2023Q3
987
159.93M
74.32%
-12.21M
2023Q2
996
162.43M
75.49%
-6.05M
2023Q1
1001
160.07M
74.44%
-9.45M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Wellington Management Company, LLP
24.44M
11.29%
+1.15M
+4.92%
Mar 31, 2025
MFS Investment Management
24.26M
11.2%
+24.26M
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
20.17M
9.31%
-350.47K
-1.71%
Jun 16, 2025
The Vanguard Group, Inc.
8.78M
4.06%
+245.16K
+2.87%
Mar 31, 2025
Amundi Asset Management, SAS
4.19M
1.94%
-516.05K
-10.96%
Mar 31, 2025
T. Rowe Price International Ltd
4.15M
1.92%
+4.01M
+2.89K%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
3.96M
1.83%
-111.67K
-2.74%
Dec 31, 2024
EARNEST Partners, LLC
3.81M
1.76%
+3.81M
--
Mar 31, 2025
DWS Investments UK Limited
3.43M
1.58%
+1.29M
+60.58%
Mar 31, 2025
Swedbank Robur Fonder AB
3.06M
1.41%
+186.76K
+6.51%
May 31, 2025
더 보기
관련 ETF
마지막 업데이트: Fri, Jun 6
마지막 업데이트: Fri, Jun 6
이름
비율
First Trust Nasdaq Lux Digi Health Solutions ETF
4.69%
Global X Genomics & Biotechnology ETF
3.96%
Invesco Biotechnology & Genome ETF
3.29%
ROBO Global Healthcare Technology & Innovation ETF
1.8%
Franklin Genomic Advancements ETF
1.75%
VanEck Biotech ETF
1.74%
iShares Health Innovation Active ETF
1.02%
Harbor Long-Short Equity ETF
0.9%
FlexShares US Quality Low Volatility Index Fund
0.85%
WisdomTree US AI Enhanced Value Fund
0.79%
더 보기
First Trust Nasdaq Lux Digi Health Solutions ETF
비율4.69%
Global X Genomics & Biotechnology ETF
비율3.96%
Invesco Biotechnology & Genome ETF
비율3.29%
ROBO Global Healthcare Technology & Innovation ETF
비율1.8%
Franklin Genomic Advancements ETF
비율1.75%
VanEck Biotech ETF
비율1.74%
iShares Health Innovation Active ETF
비율1.02%
Harbor Long-Short Equity ETF
비율0.9%
FlexShares US Quality Low Volatility Index Fund
비율0.85%
WisdomTree US AI Enhanced Value Fund
비율0.79%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
날짜
유형
비율
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
